[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Orthopedic Cell Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

July 2022 | 111 pages | ID: G6F37BE2F254EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Orthopedic Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Orthopedic Cell Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Fractures accounting for % of the Orthopedic Cell Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Platelet-rich Plasma Injection segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Orthopedic Cell Therapy include Medtronic, Genzyme, DePuy Synthes, Anika Therapeutics, and Ferring Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Orthopedic Cell Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • Platelet-rich Plasma Injection
  • Bone Marrow Therapy
  • Others
Market segment by Application, can be divided into
  • Fractures
  • Soft Tissue Contusions
  • Osteoarthritis
  • Others
Market segment by players, this report covers
  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surgical
  • Fidia Pharmaceuticals
  • MTF
  • Orthofix
  • Arthrex
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Orthopedic Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Orthopedic Cell Therapy, with revenue, gross margin and global market share of Orthopedic Cell Therapy from 2019 to 2022.

Chapter 3, the Orthopedic Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Orthopedic Cell Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Orthopedic Cell Therapy research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Orthopedic Cell Therapy
1.2 Classification of Orthopedic Cell Therapy by Type
  1.2.1 Overview: Global Orthopedic Cell Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global Orthopedic Cell Therapy Revenue Market Share by Type in 2021
  1.2.3 Platelet-rich Plasma Injection
  1.2.4 Bone Marrow Therapy
  1.2.5 Others
1.3 Global Orthopedic Cell Therapy Market by Application
  1.3.1 Overview: Global Orthopedic Cell Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Fractures
  1.3.3 Soft Tissue Contusions
  1.3.4 Osteoarthritis
  1.3.5 Others
1.4 Global Orthopedic Cell Therapy Market Size & Forecast
1.5 Global Orthopedic Cell Therapy Market Size and Forecast by Region
  1.5.1 Global Orthopedic Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global Orthopedic Cell Therapy Market Size by Region, (2017-2022)
  1.5.3 North America Orthopedic Cell Therapy Market Size and Prospect (2017-2028)
  1.5.4 Europe Orthopedic Cell Therapy Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific Orthopedic Cell Therapy Market Size and Prospect (2017-2028)
  1.5.6 South America Orthopedic Cell Therapy Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa Orthopedic Cell Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Orthopedic Cell Therapy Market Drivers
  1.6.2 Orthopedic Cell Therapy Market Restraints
  1.6.3 Orthopedic Cell Therapy Trends Analysis

2 COMPANY PROFILES

2.1 Medtronic
  2.1.1 Medtronic Details
  2.1.2 Medtronic Major Business
  2.1.3 Medtronic Orthopedic Cell Therapy Product and Solutions
  2.1.4 Medtronic Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 Medtronic Recent Developments and Future Plans
2.2 Genzyme
  2.2.1 Genzyme Details
  2.2.2 Genzyme Major Business
  2.2.3 Genzyme Orthopedic Cell Therapy Product and Solutions
  2.2.4 Genzyme Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 Genzyme Recent Developments and Future Plans
2.3 DePuy Synthes
  2.3.1 DePuy Synthes Details
  2.3.2 DePuy Synthes Major Business
  2.3.3 DePuy Synthes Orthopedic Cell Therapy Product and Solutions
  2.3.4 DePuy Synthes Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 DePuy Synthes Recent Developments and Future Plans
2.4 Anika Therapeutics
  2.4.1 Anika Therapeutics Details
  2.4.2 Anika Therapeutics Major Business
  2.4.3 Anika Therapeutics Orthopedic Cell Therapy Product and Solutions
  2.4.4 Anika Therapeutics Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Anika Therapeutics Recent Developments and Future Plans
2.5 Ferring Pharmaceuticals
  2.5.1 Ferring Pharmaceuticals Details
  2.5.2 Ferring Pharmaceuticals Major Business
  2.5.3 Ferring Pharmaceuticals Orthopedic Cell Therapy Product and Solutions
  2.5.4 Ferring Pharmaceuticals Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 Ferring Pharmaceuticals Recent Developments and Future Plans
2.6 Stryker
  2.6.1 Stryker Details
  2.6.2 Stryker Major Business
  2.6.3 Stryker Orthopedic Cell Therapy Product and Solutions
  2.6.4 Stryker Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 Stryker Recent Developments and Future Plans
2.7 NuVasive
  2.7.1 NuVasive Details
  2.7.2 NuVasive Major Business
  2.7.3 NuVasive Orthopedic Cell Therapy Product and Solutions
  2.7.4 NuVasive Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 NuVasive Recent Developments and Future Plans
2.8 Bioventus
  2.8.1 Bioventus Details
  2.8.2 Bioventus Major Business
  2.8.3 Bioventus Orthopedic Cell Therapy Product and Solutions
  2.8.4 Bioventus Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.8.5 Bioventus Recent Developments and Future Plans
2.9 Zimmer Biomet
  2.9.1 Zimmer Biomet Details
  2.9.2 Zimmer Biomet Major Business
  2.9.3 Zimmer Biomet Orthopedic Cell Therapy Product and Solutions
  2.9.4 Zimmer Biomet Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.9.5 Zimmer Biomet Recent Developments and Future Plans
2.10 Integra LifeSciences
  2.10.1 Integra LifeSciences Details
  2.10.2 Integra LifeSciences Major Business
  2.10.3 Integra LifeSciences Orthopedic Cell Therapy Product and Solutions
  2.10.4 Integra LifeSciences Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.10.5 Integra LifeSciences Recent Developments and Future Plans
2.11 RTI Surgical
  2.11.1 RTI Surgical Details
  2.11.2 RTI Surgical Major Business
  2.11.3 RTI Surgical Orthopedic Cell Therapy Product and Solutions
  2.11.4 RTI Surgical Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.11.5 RTI Surgical Recent Developments and Future Plans
2.12 Fidia Pharmaceuticals
  2.12.1 Fidia Pharmaceuticals Details
  2.12.2 Fidia Pharmaceuticals Major Business
  2.12.3 Fidia Pharmaceuticals Orthopedic Cell Therapy Product and Solutions
  2.12.4 Fidia Pharmaceuticals Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.12.5 Fidia Pharmaceuticals Recent Developments and Future Plans
2.13 MTF
  2.13.1 MTF Details
  2.13.2 MTF Major Business
  2.13.3 MTF Orthopedic Cell Therapy Product and Solutions
  2.13.4 MTF Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.13.5 MTF Recent Developments and Future Plans
2.14 Orthofix
  2.14.1 Orthofix Details
  2.14.2 Orthofix Major Business
  2.14.3 Orthofix Orthopedic Cell Therapy Product and Solutions
  2.14.4 Orthofix Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.14.5 Orthofix Recent Developments and Future Plans
2.15 Arthrex
  2.15.1 Arthrex Details
  2.15.2 Arthrex Major Business
  2.15.3 Arthrex Orthopedic Cell Therapy Product and Solutions
  2.15.4 Arthrex Orthopedic Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.15.5 Arthrex Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Orthopedic Cell Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 Orthopedic Cell Therapy Players Market Share in 2021
  3.2.2 Top 10 Orthopedic Cell Therapy Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 Orthopedic Cell Therapy Players Head Office, Products and Services Provided
3.4 Orthopedic Cell Therapy Mergers & Acquisitions
3.5 Orthopedic Cell Therapy New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Orthopedic Cell Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Orthopedic Cell Therapy Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Orthopedic Cell Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Orthopedic Cell Therapy Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Orthopedic Cell Therapy Revenue by Type (2017-2028)
6.2 North America Orthopedic Cell Therapy Revenue by Application (2017-2028)
6.3 North America Orthopedic Cell Therapy Market Size by Country
  6.3.1 North America Orthopedic Cell Therapy Revenue by Country (2017-2028)
  6.3.2 United States Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  6.3.3 Canada Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  6.3.4 Mexico Orthopedic Cell Therapy Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Orthopedic Cell Therapy Revenue by Type (2017-2028)
7.2 Europe Orthopedic Cell Therapy Revenue by Application (2017-2028)
7.3 Europe Orthopedic Cell Therapy Market Size by Country
  7.3.1 Europe Orthopedic Cell Therapy Revenue by Country (2017-2028)
  7.3.2 Germany Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  7.3.3 France Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  7.3.5 Russia Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  7.3.6 Italy Orthopedic Cell Therapy Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Orthopedic Cell Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Orthopedic Cell Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Orthopedic Cell Therapy Market Size by Region
  8.3.1 Asia-Pacific Orthopedic Cell Therapy Revenue by Region (2017-2028)
  8.3.2 China Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  8.3.3 Japan Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  8.3.4 South Korea Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  8.3.5 India Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  8.3.7 Australia Orthopedic Cell Therapy Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Orthopedic Cell Therapy Revenue by Type (2017-2028)
9.2 South America Orthopedic Cell Therapy Revenue by Application (2017-2028)
9.3 South America Orthopedic Cell Therapy Market Size by Country
  9.3.1 South America Orthopedic Cell Therapy Revenue by Country (2017-2028)
  9.3.2 Brazil Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  9.3.3 Argentina Orthopedic Cell Therapy Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Orthopedic Cell Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Orthopedic Cell Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Orthopedic Cell Therapy Market Size by Country
  10.3.1 Middle East & Africa Orthopedic Cell Therapy Revenue by Country (2017-2028)
  10.3.2 Turkey Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia Orthopedic Cell Therapy Market Size and Forecast (2017-2028)
  10.3.4 UAE Orthopedic Cell Therapy Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

LIST OF TABLES

Table 1. Global Orthopedic Cell Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Orthopedic Cell Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Orthopedic Cell Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Orthopedic Cell Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Orthopedic Cell Therapy Revenue Market Share by Region (2023-2028)
Table 6. Medtronic Corporate Information, Head Office, and Major Competitors
Table 7. Medtronic Major Business
Table 8. Medtronic Orthopedic Cell Therapy Product and Solutions
Table 9. Medtronic Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Genzyme Corporate Information, Head Office, and Major Competitors
Table 11. Genzyme Major Business
Table 12. Genzyme Orthopedic Cell Therapy Product and Solutions
Table 13. Genzyme Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. DePuy Synthes Corporate Information, Head Office, and Major Competitors
Table 15. DePuy Synthes Major Business
Table 16. DePuy Synthes Orthopedic Cell Therapy Product and Solutions
Table 17. DePuy Synthes Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Anika Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Anika Therapeutics Major Business
Table 20. Anika Therapeutics Orthopedic Cell Therapy Product and Solutions
Table 21. Anika Therapeutics Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Ferring Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Ferring Pharmaceuticals Major Business
Table 24. Ferring Pharmaceuticals Orthopedic Cell Therapy Product and Solutions
Table 25. Ferring Pharmaceuticals Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Stryker Corporate Information, Head Office, and Major Competitors
Table 27. Stryker Major Business
Table 28. Stryker Orthopedic Cell Therapy Product and Solutions
Table 29. Stryker Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. NuVasive Corporate Information, Head Office, and Major Competitors
Table 31. NuVasive Major Business
Table 32. NuVasive Orthopedic Cell Therapy Product and Solutions
Table 33. NuVasive Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Bioventus Corporate Information, Head Office, and Major Competitors
Table 35. Bioventus Major Business
Table 36. Bioventus Orthopedic Cell Therapy Product and Solutions
Table 37. Bioventus Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Zimmer Biomet Corporate Information, Head Office, and Major Competitors
Table 39. Zimmer Biomet Major Business
Table 40. Zimmer Biomet Orthopedic Cell Therapy Product and Solutions
Table 41. Zimmer Biomet Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Integra LifeSciences Corporate Information, Head Office, and Major Competitors
Table 43. Integra LifeSciences Major Business
Table 44. Integra LifeSciences Orthopedic Cell Therapy Product and Solutions
Table 45. Integra LifeSciences Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. RTI Surgical Corporate Information, Head Office, and Major Competitors
Table 47. RTI Surgical Major Business
Table 48. RTI Surgical Orthopedic Cell Therapy Product and Solutions
Table 49. RTI Surgical Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Fidia Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 51. Fidia Pharmaceuticals Major Business
Table 52. Fidia Pharmaceuticals Orthopedic Cell Therapy Product and Solutions
Table 53. Fidia Pharmaceuticals Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. MTF Corporate Information, Head Office, and Major Competitors
Table 55. MTF Major Business
Table 56. MTF Orthopedic Cell Therapy Product and Solutions
Table 57. MTF Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Orthofix Corporate Information, Head Office, and Major Competitors
Table 59. Orthofix Major Business
Table 60. Orthofix Orthopedic Cell Therapy Product and Solutions
Table 61. Orthofix Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Arthrex Corporate Information, Head Office, and Major Competitors
Table 63. Arthrex Major Business
Table 64. Arthrex Orthopedic Cell Therapy Product and Solutions
Table 65. Arthrex Orthopedic Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Orthopedic Cell Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Orthopedic Cell Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Orthopedic Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Orthopedic Cell Therapy Players Head Office, Products and Services Provided
Table 70. Orthopedic Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 71. Orthopedic Cell Therapy New Entrants and Expansion Plans
Table 72. Global Orthopedic Cell Therapy Revenue (USD Million) by Type (2017-2022)
Table 73. Global Orthopedic Cell Therapy Revenue Share by Type (2017-2022)
Table 74. Global Orthopedic Cell Therapy Revenue Forecast by Type (2023-2028)
Table 75. Global Orthopedic Cell Therapy Revenue by Application (2017-2022)
Table 76. Global Orthopedic Cell Therapy Revenue Forecast by Application (2023-2028)
Table 77. North America Orthopedic Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Orthopedic Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Orthopedic Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Orthopedic Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Orthopedic Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Orthopedic Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Orthopedic Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Orthopedic Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Orthopedic Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Orthopedic Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Orthopedic Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Orthopedic Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Orthopedic Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Orthopedic Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Orthopedic Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Orthopedic Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Orthopedic Cell Therapy Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Orthopedic Cell Therapy Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Orthopedic Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Orthopedic Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Orthopedic Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Orthopedic Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Orthopedic Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Orthopedic Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Orthopedic Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Orthopedic Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Orthopedic Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Orthopedic Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Orthopedic Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Orthopedic Cell Therapy Revenue by Country (2023-2028) & (USD Million)

LIST OF FIGURES

Figure 1. Orthopedic Cell Therapy Picture
Figure 2. Global Orthopedic Cell Therapy Revenue Market Share by Type in 2021
Figure 3. Platelet-rich Plasma Injection
Figure 4. Bone Marrow Therapy
Figure 5. Others
Figure 6. Orthopedic Cell Therapy Revenue Market Share by Application in 2021
Figure 7. Fractures Picture
Figure 8. Soft Tissue Contusions Picture
Figure 9. Osteoarthritis Picture
Figure 10. Others Picture
Figure 11. Global Orthopedic Cell Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Orthopedic Cell Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Orthopedic Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 14. Global Orthopedic Cell Therapy Revenue Market Share by Region in 2021
Figure 15. North America Orthopedic Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Orthopedic Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Orthopedic Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Orthopedic Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Orthopedic Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Orthopedic Cell Therapy Market Drivers
Figure 21. Orthopedic Cell Therapy Market Restraints
Figure 22. Orthopedic Cell Therapy Market Trends
Figure 23. Medtronic Recent Developments and Future Plans
Figure 24. Genzyme Recent Developments and Future Plans
Figure 25. DePuy Synthes Recent Developments and Future Plans
Figure 26. Anika Therapeutics Recent Developments and Future Plans
Figure 27. Ferring Pharmaceuticals Recent Developments and Future Plans
Figure 28. Stryker Recent Developments and Future Plans
Figure 29. NuVasive Recent Developments and Future Plans
Figure 30. Bioventus Recent Developments and Future Plans
Figure 31. Zimmer Biomet Recent Developments and Future Plans
Figure 32. Integra LifeSciences Recent Developments and Future Plans
Figure 33. RTI Surgical Recent Developments and Future Plans
Figure 34. Fidia Pharmaceuticals Recent Developments and Future Plans
Figure 35. MTF Recent Developments and Future Plans
Figure 36. Orthofix Recent Developments and Future Plans
Figure 37. Arthrex Recent Developments and Future Plans
Figure 38. Global Orthopedic Cell Therapy Revenue Share by Players in 2021
Figure 39. Orthopedic Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Orthopedic Cell Therapy Revenue Market Share in 2021
Figure 41. Global Top 10 Players Orthopedic Cell Therapy Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Orthopedic Cell Therapy Revenue Share by Type in 2021
Figure 44. Global Orthopedic Cell Therapy Market Share Forecast by Type (2023-2028)
Figure 45. Global Orthopedic Cell Therapy Revenue Share by Application in 2021
Figure 46. Global Orthopedic Cell Therapy Market Share Forecast by Application (2023-2028)
Figure 47. North America Orthopedic Cell Therapy Sales Market Share by Type (2017-2028)
Figure 48. North America Orthopedic Cell Therapy Sales Market Share by Application (2017-2028)
Figure 49. North America Orthopedic Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 50. United States Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Orthopedic Cell Therapy Sales Market Share by Type (2017-2028)
Figure 54. Europe Orthopedic Cell Therapy Sales Market Share by Application (2017-2028)
Figure 55. Europe Orthopedic Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 56. Germany Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Orthopedic Cell Therapy Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Orthopedic Cell Therapy Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Orthopedic Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 64. China Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Orthopedic Cell Therapy Sales Market Share by Type (2017-2028)
Figure 71. South America Orthopedic Cell Therapy Sales Market Share by Application (2017-2028)
Figure 72. South America Orthopedic Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Orthopedic Cell Therapy Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Orthopedic Cell Therapy Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Orthopedic Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Orthopedic Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source


More Publications